» Articles » PMID: 27884851

Influence of Preinfarction Angina and Coronary Collateral Blood Flow on the Efficacy of Remote Ischaemic Conditioning in Patients with ST Segment Elevation Myocardial Infarction: Post Hoc Subgroup Analysis of a Randomised Controlled Trial

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Nov 26
PMID 27884851
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Remote ischaemic conditioning (RIC) confers cardioprotection in patients with ST segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI). We investigated whether preinfarction angina and coronary collateral blood flow (CCBF) to the infarct-related artery modify the efficacy of RIC.

Design: Post hoc subgroup analysis of a randomised controlled trial.

Participants: A total of 139 patients with STEMI randomised to treatment with pPCI or RIC+pPCI.

Interventions: RIC was performed prior to pPCI as four cycles of 5 min upper arm ischaemia and reperfusion with a blood pressure cuff.

Primary Outcome Measure: Myocardial salvage index (MSI) assessed by single-photon emission computerised tomography. We evaluated the efficacy of RIC in subgroups of patients with or without preinfarction angina or CCBF.

Results: Of 139 patients included in the study, 109 had available data for preinfarction angina status and 54 had preinfarction angina. Among 83 patients with Thrombolysis In Myocardial Infarction flow 0/1 on arrival, 43 had CCBF. Overall, RIC+pPCI increased median MSI compared with pPCI alone (0.75 vs 0.56, p=0.045). Mean MSI did not differ between patients with and without preinfarction angina in either the pPCI alone (0.58 and 0.57; 95% CI -0.17 to 0.19, p=0.94) or the RIC+pPCI group (0.66 and 0.69; 95% CI -0.18 to 0.10, p=0.58). Mean MSI did not differ between patients with and without CCBF in the pPCI alone group (0.51 and 0.55; 95% CI -0.20 to 0.13, p=0.64), but was increased in patients with CCBF versus without CCBF in the RIC+pPCI group (0.75 vs 0.58; 95% CI 0.03 to 0.31, p=0.02; effect modification from CCBF on the effect of RIC on MSI, p=0.06).

Conclusions: Preinfarction angina did not modify the efficacy of RIC in patients with STEMI undergoing pPCI. CCBF to the infarct-related artery seems to be of importance for the cardioprotective efficacy of RIC.

Trial Registration Number: NCT00435266, Post-results.

Citing Articles

Chronic remote ischemic conditioning treatment in patients with chronic stable angina (EARLY-MYO-CSA): a randomized, controlled proof-of-concept trial.

Guo Q, Zhao Z, Yang F, Zhang Z, Rao X, Cui J BMC Med. 2023; 21(1):324.

PMID: 37626410 PMC: 10463998. DOI: 10.1186/s12916-023-03041-z.


Prognostic Significance of Percutaneous Coronary Intervention for First Acute Myocardial Infarction with Heart Failure: Five-Year Follow-Up Results.

Cheng Z, Shi Y, Peng H, Zhao D, Fan Q, Liu J Cardiol Res Pract. 2022; 2022:5791295.

PMID: 36386562 PMC: 9649329. DOI: 10.1155/2022/5791295.


Remote ischaemic preconditioning influences the levels of acylcarnitines in vascular surgery: a randomised clinical trial.

Kasepalu T, Kuusik K, Lepner U, Starkopf J, Zilmer M, Eha J Nutr Metab (Lond). 2020; 17:76.

PMID: 32968425 PMC: 7501679. DOI: 10.1186/s12986-020-00495-3.


Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?.

Kleinbongard P, Botker H, Ovize M, Hausenloy D, Heusch G Br J Pharmacol. 2019; 177(23):5252-5269.

PMID: 31430831 PMC: 7680006. DOI: 10.1111/bph.14839.


Influence of Cardiovascular Risk Factors, Comorbidities, Medication Use and Procedural Variables on Remote Ischemic Conditioning Efficacy in Patients with ST-Segment Elevation Myocardial Infarction.

Pryds K, Hjortbak M, Schmidt M Int J Mol Sci. 2019; 20(13).

PMID: 31269650 PMC: 6650921. DOI: 10.3390/ijms20133246.


References
1.
Zimarino M, DAndreamatteo M, Waksman R, Epstein S, De Caterina R . The dynamics of the coronary collateral circulation. Nat Rev Cardiol. 2014; 11(4):191-7. DOI: 10.1038/nrcardio.2013.207. View

2.
Ovize M, Thibault H, Przyklenk K . Myocardial conditioning: opportunities for clinical translation. Circ Res. 2013; 113(4):439-50. DOI: 10.1161/CIRCRESAHA.113.300764. View

3.
Botker H, Kharbanda R, Schmidt M, Bottcher M, Kaltoft A, Terkelsen C . Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010; 375(9716):727-34. DOI: 10.1016/S0140-6736(09)62001-8. View

4.
Heusch G . Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug?. Circulation. 2001; 103(24):2876-8. DOI: 10.1161/01.cir.103.24.2876. View

5.
Argaud L, Rioufol G, Lievre M, Bontemps L, Legalery P, Stumpf M . Preconditioning during coronary angioplasty: no influence of collateral perfusion or the size of the area at risk. Eur Heart J. 2004; 25(22):2019-25. DOI: 10.1016/j.ehj.2004.07.040. View